Clinical trial
Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III…
NCT00379717 · AZ-VUB, Other · Unknown status
Key facts
| NCT number | NCT00379717 |
|---|---|
| Title | Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) |
| Official title | Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC): a Phase I/II Trial of Radiation Dose Escalation and Fixed Dose Chemotherapy. |
| Lead sponsor | AZ-VUB, Other |
| Collaborators | Sanofi Industry |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Non-Small-Cell Lung Carcinoma |
| Intervention type | Device, Drug |
| Interventions | Cisplatinum, Docetaxel, Tomotherapy |
| Enrollment | 30 |
| Start date | Nov 1, 2006 |
| Completion | Apr 1, 2008 |
| First posted | Sep 22, 2006 |
| Last update posted | Mar 13, 2008 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: